This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Christopher Daniel Boone
Introduction
Christopher Daniel Boone, an accomplished inventor based in College Station, TX, has made significant strides in the field of vaccine development. His expertise is particularly focused on enhancing the stability and safety of poliovirus vaccine components through innovative methodologies.
Latest Patents
Boone holds a noteworthy patent, titled "N-antigenic form poliovirus virus-like particles comprising thermostable mutations." This invention presents compositions of virus-like particles (VLPs) of poliovirus that incorporate one or more stabilizing mutations. These mutations enhance the thermostability of the N-antigenic form of the VLPs, making them non-infectious and thus safer for use in vaccine development and administration to clinical subjects.
Career Highlights
Christopher is associated with the University of Florida Research Foundation, Incorporated, where his research focuses on the intersection of virology and vaccine innovation. His work has not only contributed to academic discussions but has also advanced practical applications in public health.
Collaborations
During his career, Boone has collaborated with notable coworkers, including James B. Flanegan and Robert McKenna. These partnerships have fostered an environment of shared knowledge and innovation, further enhancing the impact of their research in the realm of vaccine development.
Conclusion
Christopher Daniel Boone exemplifies the spirit of innovation within the scientific community. His contributions, particularly through his patent on thermostable poliovirus-like particles, mark significant advancements in vaccine safety and efficacy. Through his work at the University of Florida Research Foundation, he continues to pave the way for future scientific breakthroughs.